Peptide record

TPDB10389

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10389
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 24-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FLGAIAGVAAKFLPKVFCFITKKC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C125H198N28O26S2
RNDEQHMSWY
AKF
2573.24
10.17
4
0
14
+4
-1.11
1.238
105.83
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
0.05
3
Residue Composition
number
4
A
0
R
0
N
0
D
2
C
0
E
0
Q
2
G
0
H
2
I
2
L
4
K
0
M
4
F
1
P
0
S
1
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 4 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 2 H: 0 I: 2 L: 2 K: 4 M: 0 F: 4 P: 1 S: 0 T: 1 W: 0 Y: 0 V: 2
Chemical Descriptors
24 reviewed residue count
C125H198N28O26S2 sequence-only estimate (linear, free termini)
2573.24 sequence-only estimate (linear, free termini)
10.17 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
-1.11 sequence-only estimate (linear, free termini)
1.238 sequence-only estimate (linear, free termini)
Evidence Records 4 records
Evidence 1 Activity

Activity

LC50
Hemolysis
8 mM
[Ref.19379837] LC50=8 mM against human erythrocytes

Target

human erythrocytes

Source & Reference

Hemolytik PD_Hemolysis
DRAMP4
Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug 150(2):150-154.

Other

Source Activity Label Source Definition
Hemolysis
Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
8 µM
Hemolytic Cytotoxic
50% Hemolysis | 8 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae). | Comp Biochem Physiol C Toxicol Pharmacol | 2009
Evidence 3 Activity

Activity

LC50
Toxicity
8 mM
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.19379837] LC50=8 mM against human erythrocytes | Cytotoxicity: [Ref.19379837] LC50=4mM against HepG2 hepatoma-derived cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug 150(2):150-154.
Evidence 4 Hemolysis

Activity

8 mM
LC50
[Ref.19379837] LC50=8 mM against human erythrocytes
Hemolysis

Target

human erythrocytes

Source & Reference

HemoPI PD_Hemolysis
Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug 150(2):150-154.
DRAMP4
PD_Hemolysis